Session Title: GLP-1s and Vaccines: Examining Business Impacts and Trends in Retail Pharmacy (1 CE credit)
Session Description: This session will discuss current trends and profitability impacts of providing GLP-1s and vaccines in the retail pharmacy setting.
Session Objectives:
- Identify variables driving growth or decline in these dispensing categories inside retail pharmacies.
- Recognize the business impact that GLP-1s are having on both the diabetes medication category and other secondary purchase categories.
- Discuss how vaccines can contribute to the bottom line of your pharmacy business.
Bio: Scott Biggs is Director of Supplier Services at IQVIA (previously known as QuintilesIMS), the world’s largest pharmaceutical information company, serving over 101 countries. He has been with IQVIA since 2011.
Prior to IQVIA, Scott worked for other pharmaceutical information companies for several years and worked at Rite Aid Corporation in multiple roles for over 10 years. Scott received a BS degree from Penn State University in Accounting and has been working with pharmacy data for 30 years.
In his role at IQVIA, Scott has worked with retailers, software vendors and other data suppliers where he has helped them to understand their performance in the marketplace through business reviews and market analysis.